1. |
ENSGALG00000011129 |
ENSGALG00000011129 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
2. |
APLNR |
ENSGALG00000004841 |
176 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
apelin receptor [Source:HGNC Symbol;Acc:HGNC:339] |
3. |
CER1 |
ENSGALG00000005434 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
cerberus 1, DAN family BMP antagonist [Source:NCBI gene;Acc:395623] |
4. |
SPIC |
ENSGALG00000027209 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
Spi-C transcription factor [Source:HGNC Symbol;Acc:HGNC:29549] |
5. |
SH3D19 |
ENSGALG00000010081 |
52 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
SH3 domain containing 19 [Source:HGNC Symbol;Acc:HGNC:30418] |
6. |
LOC426355 |
ENSGALG00000028985 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
t-SNARE domain-containing protein 1-like, transcript variant X2 |
7. |
ETV3 |
ENSGALG00000000669 |
7 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
ETS variant 3 [Source:HGNC Symbol;Acc:HGNC:3492] |
8. |
ENSGALG00000025912 |
ENSGALG00000025912 |
4 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
9. |
PIGV |
ENSGALG00000039883 |
32 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031] |
10. |
THSD1 |
ENSGALG00000028083 |
2 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
thrombospondin type 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:17754] |
11. |
PCDH7 |
ENSGALG00000033883 |
6 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
protocadherin 7 [Source:HGNC Symbol;Acc:HGNC:8659] |
12. |
PTRF |
|
7 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
polymerase I and transcript release factor |
13. |
MEGF9 |
|
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
multiple EGF-like-domains 9 |
14. |
PI15 |
ENSGALG00000029264 |
21 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
peptidase inhibitor 15 [Source:NCBI gene;Acc:374241] |
15. |
B3GALT6 |
ENSGALG00000001859 |
5 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
beta-1,3-galactosyltransferase 6 |
16. |
TMEM255A |
ENSGALG00000008604 |
7 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
transmembrane protein 255A [Source:HGNC Symbol;Acc:HGNC:26086] |
17. |
ENSGALG00000020753 |
ENSGALG00000020753 |
159 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
18. |
ENSGALG00000023704 |
ENSGALG00000023704 |
2 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
19. |
KCTD15 |
ENSGALG00000004907 |
8 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
potassium channel tetramerization domain containing 15 [Source:HGNC Symbol;Acc:HGNC:23297] |
20. |
CARD11 |
ENSGALG00000004398 |
58 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
caspase recruitment domain family member 11 [Source:NCBI gene;Acc:416476] |
21. |
MIP-3ALPHA |
MIP-3ALPHA |
14 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
22. |
GPR34 |
ENSGALG00000016227 |
9 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
G protein-coupled receptor 34 [Source:NCBI gene;Acc:771199] |
23. |
C7orf72 |
|
1 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
chromosome 7 open reading frame 72, transcript variant X2 |
24. |
ADAMTS15 |
ENSGALG00000001407 |
11 |
0.959 |
- |
- |
- |
0.959 |
- |
- |
- |
- |
- |
- |
ADAM metallopeptidase with thrombospondin type 1 motif 15 [Source:HGNC Symbol;Acc:HGNC:16305] |
25. |
CNNM1 |
ENSGALG00000007489 |
43 |
0.927 |
- |
- |
- |
0.927 |
- |
- |
- |
- |
- |
- |
cyclin and CBS domain divalent metal cation transport mediator 1 [Source:HGNC Symbol;Acc:HGNC:102] |
26. |
SLC39A12 |
ENSGALG00000008602 |
6 |
0.859 |
- |
- |
- |
0.859 |
- |
- |
- |
- |
- |
- |
solute carrier family 39 member 12 [Source:HGNC Symbol;Acc:HGNC:20860] |
27. |
PHEX |
ENSGALG00000016375 |
4 |
0.853 |
- |
- |
- |
0.853 |
- |
- |
- |
- |
- |
- |
phosphate regulating endopeptidase homolog, X-linked [Source:NCBI gene;Acc:395777] |
28. |
VAT1L |
ENSGALG00000013225 |
3 |
0.834 |
- |
- |
- |
0.834 |
- |
- |
- |
- |
- |
- |
vesicle amine transport 1 like [Source:HGNC Symbol;Acc:HGNC:29315] |
29. |
ESR2 |
ENSGALG00000011801 |
7 |
0.834 |
- |
- |
- |
0.834 |
- |
- |
- |
- |
- |
- |
estrogen receptor 2 [Source:NCBI gene;Acc:395575] |
30. |
FNDC7 |
ENSGALG00000001983 |
24 |
0.827 |
- |
- |
- |
0.827 |
- |
- |
- |
- |
- |
- |
fibronectin type III domain containing 7 [Source:HGNC Symbol;Acc:HGNC:26668] |
31. |
ITGB2 |
ENSGALG00000007511 |
46 |
0.789 |
- |
- |
- |
0.789 |
- |
- |
- |
- |
- |
- |
integrin subunit beta 2 [Source:NCBI gene;Acc:396181] |
32. |
SLC25A25 |
ENSGALG00000005095 |
4 |
0.751 |
- |
- |
- |
0.751 |
- |
- |
- |
- |
- |
- |
solute carrier family 25 member 25 [Source:HGNC Symbol;Acc:HGNC:20663] |
33. |
CLCN4 |
ENSGALG00000016607 |
8 |
0.751 |
- |
- |
- |
0.751 |
- |
- |
- |
- |
- |
- |
chloride voltage-gated channel 4 [Source:HGNC Symbol;Acc:HGNC:2022] |
34. |
ENSGALG00000016732 |
ENSGALG00000016732 |
24 |
0.742 |
- |
- |
- |
0.742 |
- |
- |
- |
- |
- |
- |
|
35. |
HPS3 |
ENSGALG00000040089 |
44 |
0.733 |
- |
- |
- |
0.733 |
- |
- |
- |
- |
- |
- |
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 [Source:HGNC Symbol;Acc:HGNC:15597] |